<SEC-DOCUMENT>0001193125-22-170177.txt : 20220608
<SEC-HEADER>0001193125-22-170177.hdr.sgml : 20220608
<ACCEPTANCE-DATETIME>20220608160601
ACCESSION NUMBER:		0001193125-22-170177
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20220608
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220608
DATE AS OF CHANGE:		20220608

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viracta Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001061027
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943295878
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51531
		FILM NUMBER:		221003544

	BUSINESS ADDRESS:	
		STREET 1:		2533 S COAST HWY 101
		STREET 2:		SUITE 210
		CITY:			CARDIFF
		STATE:			CA
		ZIP:			92007
		BUSINESS PHONE:		858-400-8470

	MAIL ADDRESS:	
		STREET 1:		2533 S COAST HWY 101
		STREET 2:		SUITE 210
		CITY:			CARDIFF
		STATE:			CA
		ZIP:			92007

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MOSAIC PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19980709

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUNESIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19980501
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d311733d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:virx="http://viracta.com/20220608" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-06-08_to_2022-06-08">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-06-08_to_2022-06-08">0001061027</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="virx-20220608.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-06-08_to_2022-06-08"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001061027</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-06-08</xbrli:startDate> <xbrli:endDate>2022-06-08</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-06-08_to_2022-06-08">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt:datemonthdayyearen">June&#160;8, 2022</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2022-06-08_to_2022-06-08">VIRACTA THERAPEUTICS, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-06-08_to_2022-06-08">000-51531</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-06-08_to_2022-06-08">94-3295878</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-06-08_to_2022-06-08">2533 S Coast Hwy 101</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2022-06-08_to_2022-06-08">Suite 210</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-06-08_to_2022-06-08">Cardiff</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-06-08_to_2022-06-08">92007</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-06-08_to_2022-06-08">(858)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-06-08_to_2022-06-08">400-8470</ix:nonNumeric></span></p> <p style="margin-top:20pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-06-08_to_2022-06-08">Common Stock, $0.0001 par value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-06-08_to_2022-06-08">VIRX</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-06-08_to_2022-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Viracta Therapeutics, Inc. (the &#8220;Company&#8221;) held its 2022 annual meeting of stockholders on June&#160;8, 2022 (the &#8220;Annual Meeting&#8221;). At the Annual Meeting, as reported below in Item 5.07, the Company&#8217;s stockholders approved the Company&#8217;s 2022 Employee Stock Purchase Plan (the &#8220;2022 ESPP&#8221;). A summary of the material terms of the 2022 ESPP is set forth in the Company&#8217;s definitive proxy statement for the Annual Meeting, which was filed with the Securities and Exchange Commission on April&#160;27, 2022. A copy of the 2022 ESPP is attached as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.07</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Submission of Matters to a Vote of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As set forth above, the Company held its Annual Meeting on June&#160;8, 2022. Of the 37,488,274 shares of the Company&#8217;s common stock outstanding as of the record date of April&#160;19, 2022, 25,950,425 shares were represented at the Annual Meeting, either by proxy or by attending the meeting. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">1.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Election of Class</span><span style="font-weight:bold"></span><span style="font-weight:bold">&#160;I Directors. </span>The following nominees were elected to serve as Class&#160;I directors, each to hold office until the Company&#8217;s 2025 annual meeting of stockholders or until his respective successor has been duly elected and qualified: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:31%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:27%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:27%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:12%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Nominee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes For</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes Withheld</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#160;&#160;Michael Huang, M.S., M.B.A.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">20,549,967</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">154,966</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">5,245,492</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#160;&#160;Sam Murphy, Ph.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">20,577,580</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">127,353</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">5,245,492</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#160;&#160;Roger J. Pomerantz, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">17,651,268</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">3,053,665</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">5,245,492</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">2.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Advisory Vote to Approve the Compensation of the Named Executive Officers. </span>The Company&#8217;s stockholders approved, on an advisory and <span style="white-space:nowrap">non-binding</span> basis, the compensation of the Company&#8217;s named executive officers as described in the Company&#8217;s proxy statement. The votes were as follows: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:27%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:21%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstentions</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center">17,312,508</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">701,418</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">2,691,007</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">5,245,492</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">3.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Approval of the 2022 Employee Stock Purchase Plan. </span>The Company&#8217;s stockholders approved the 2022 ESPP. The votes regarding the proposal were as follows: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:27%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:21%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstentions</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center">20,281,353</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">408,234</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">15,346</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">5,245,492</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">4.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Ratification of Appointment of Independent Registered Public Accounting Firm.</span> The appointment of Ernst&#160;&amp; Young LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2022 was ratified based on the following results of voting: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:27%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:21%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstentions</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center">25,872,398</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">33,915</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">44,112</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">0</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">(d) Exhibits </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d311733dex101.htm">2022 Employee Stock Purchase Plan </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:47%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:46%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Dated: June&#160;8, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel Chevallard</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Daniel Chevallard</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Chief Operating Officer and Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d311733dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VIRACTA THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2022 EMPLOYEE STOCK PURCHASE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Purpose</U>. The purpose of the Plan is to provide employees of the Company and its Designated Companies with an opportunity to purchase
Common Stock through accumulated Contributions. The Company intends for the Plan to have two components: a Code Section&nbsp;423 Component (&#147;<U>423 Component</U>&#148;) and a <FONT STYLE="white-space:nowrap">non-Code</FONT> Section&nbsp;423
Component (&#147;<U><FONT STYLE="white-space:nowrap">Non-423</FONT> Component</U>&#148;). The Company&#146;s intention is to have the 423 Component of the Plan qualify as an &#147;employee stock purchase plan&#148; under Section&nbsp;423 of the
Code. The provisions of the 423 Component, accordingly, will be construed so as to extend and limit Plan participation in a uniform and nondiscriminatory basis consistent with the requirements of Section&nbsp;423 of the Code. In addition, this Plan
authorizes the grant of an option to purchase shares of Common Stock under the <FONT STYLE="white-space:nowrap">Non-423</FONT> Component that does not qualify as an &#147;employee stock purchase plan&#148; under Section&nbsp;423 of the Code; such an
option will be granted pursuant to rules, procedures or <FONT STYLE="white-space:nowrap">sub-plans</FONT> adopted by the Administrator designed to achieve tax, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> exchange or securities laws or other
objectives for Eligible Employees and the Company. Except as otherwise provided, the <FONT STYLE="white-space:nowrap">Non-423</FONT> Component will operate and be administered in the same manner as the 423&nbsp;Component. The Company intends to
issue options under the <FONT STYLE="white-space:nowrap">Non-423</FONT> Component unless and until it may issue options under the 423 Component that are eligible to satisfy the requirements of Section&nbsp;423 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Definitions</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
&#147;<U>Administrator</U>&#148; means the Board or any Committee designated by the Board to administer the Plan pursuant to Section&nbsp;14. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) &#147;<U>Affiliate</U>&#148; means any entity, other than a Subsidiary, in which the Company has an equity or other ownership interest.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) &#147;<U>Applicable Laws</U>&#148; means the legal and regulatory requirements relating to the administration of equity-based awards
and the related issuance of shares of Common Stock under U.S. state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable securities
and exchange control laws of any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> country or jurisdiction where options are, or will be, granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) &#147;<U>Board</U>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) &#147;<U>Change in Control</U>&#148; means the occurrence of any of the following events: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) A change in the ownership of the Company<I> </I>which occurs on the date that any one person, or more than one person acting as a group
(&#147;<U>Person</U>&#148;), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than fifty percent (50%)&nbsp;of the total voting power of the stock of the Company; provided, however,
that for purposes of this subsection, (A)&nbsp;the acquisition of additional stock by any one Person, who is considered to own more than fifty percent (50%)&nbsp;of the total voting power of the stock of the Company will not be considered a Change
in Control, and (B)&nbsp;if the stockholders of the Company immediately before such change in ownership continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the
Company&#146;s voting stock immediately prior to the change in ownership, the direct or indirect beneficial ownership of fifty percent (50%) or more of the total voting power of the stock of the Company or of the ultimate parent entity of the
Company, such event will not be considered a Change in Control under this subsection (i). For this purpose, indirect beneficial ownership will include, without limitation, an interest resulting from ownership of the voting securities of one or more
corporations or other business entities which own the Company, as the case may be, either directly or through one or more subsidiary corporations or other business entities; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) A change in the effective control of the Company, which occurs on the date that a majority of members of the Board is replaced during
any twelve (12)&nbsp;month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this subsection (ii), if any Person is
considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) A change in the ownership of a substantial portion of the Company&#146;s assets, which occurs on the date that any Person acquires (or
has acquired during the twelve (12)&nbsp;month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than fifty percent (50%) of the
total gross fair market value of all of the assets of the Company immediately prior to such acquisition or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
acquisitions; provided, however, that for purposes of this subsection, the following will not constitute a change in the ownership of a substantial portion of the Company&#146;s assets:
(A)&nbsp;a transfer to an entity that is controlled by the Company&#146;s stockholders immediately after the transfer, or (B)&nbsp;a transfer of assets by the Company to: (1)&nbsp;a stockholder of the Company (immediately before the asset transfer)
in exchange for or with respect to the Company&#146;s stock, (2)&nbsp;an entity, fifty percent (50%) or more of the total value or voting power of which is owned, directly or indirectly, by the Company, (3)&nbsp;a Person, that owns, directly or
indirectly, fifty percent (50%) or more of the total value or voting power of all the outstanding stock of the Company, or (4)&nbsp;an entity, at least fifty percent (50%) of the total value or voting power of which is owned, directly or indirectly,
by a Person described in this subsection (iii)(B)(3). For purposes of this subsection, gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities
associated with such assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For purposes of this definition, Persons will be considered to be acting as a group if they are owners of a
corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control
event within the meaning of Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Further and for the avoidance of doubt, a transaction will not constitute a Change in
Control if: (i)&nbsp;its sole purpose is to change the state of the Company&#146;s incorporation, or (ii)&nbsp;its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the
Company&#146;s securities immediately before such transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) &#147;<U>Code</U>&#148; means the U.S. Internal Revenue Code of 1986,
as amended. Reference to a specific section of the Code or U.S. Treasury Regulation thereunder will include such section or regulation, any valid regulation or other official applicable guidance promulgated under such section, and any comparable
provision of any future legislation or regulation amending, supplementing or superseding such section or regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)
&#147;<U>Committee</U>&#148; means a committee of the Board appointed in accordance with Section&nbsp;14 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) &#147;<U>Common
Stock</U>&#148; means the common stock of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) &#147;<U>Company</U>&#148; means Viracta Therapeutics, Inc., a Delaware
corporation, or any successor thereto.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) &#147;<U>Compensation</U>&#148; means, unless otherwise determined by the
Administration, an Eligible Employee&#146;s base straight time gross earnings, payments for overtime and shift premium, but exclusive of payments for incentive compensation, commissions, bonuses and other similar compensation. The Administrator, in
its discretion, may, on a uniform and nondiscriminatory basis, establish a definition of Compensation from time to time prior to an Enrollment Date for all options to be granted on such Enrollment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) &#147;<U>Contributions</U>&#148; means the payroll deductions and/or other additional payments that the Company may permit to be made by a
Participant to fund the exercise of options granted pursuant to the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) &#147;<U>Designated Company</U>&#148; means any Subsidiary
or Affiliate that has been designated by the Administrator in its sole discretion as eligible to participate in the Plan. For purposes of the 423 Component, only the Company and its Subsidiaries may be Designated Companies, provided that a
Subsidiary that is a Designated Company under the 423 Component may not simultaneously be a Designated Company under the <FONT STYLE="white-space:nowrap">Non-423</FONT> Component. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) &#147;<U>Director</U>&#148; means a member of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) &#147;<U>Eligible Employee</U>&#148; means any individual who is a common law employee (and, with respect to the <FONT
STYLE="white-space:nowrap">Non-423</FONT> Component, is not classified by the Company as an intern or temporary employee) providing services to the Company or a Designated Company and is customarily employed for at least twenty (20)&nbsp;hours per
week and more than five&nbsp;(5) months in any calendar year by the Employer, or any lesser number of hours per week and/or number of months in any calendar year established by the Administrator (if required under applicable local law) for purposes
of any separate Offering or for Eligible Employees participating in the <FONT STYLE="white-space:nowrap">Non-423</FONT> Component. For purposes of the Plan, the employment relationship will be treated as continuing intact while the individual is on
sick leave or other leave of absence that the Employer approves or is legally protected under applicable local laws. Where the period of leave exceeds three (3)&nbsp;months and the individual&#146;s right to reemployment is not guaranteed either by
statute or by contract, the employment relationship will be deemed to have terminated three (3)&nbsp;months and one (1)&nbsp;day following the commencement of such leave. The Administrator, in its discretion, from time to time may, prior to an
Enrollment Date for all options to be granted on such Enrollment Date in an Offering, determine (for each Offering under the 423 Component, on a uniform </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and nondiscriminatory basis or as otherwise permitted by Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2)</FONT> that the definition of Eligible Employee will or will
not include an individual if he or she: (i)&nbsp;has not completed at least two (2)&nbsp;years of service since his or her last hire date (or such lesser period of time as may be determined by the Administrator in its discretion),
(ii)&nbsp;customarily works not more than twenty (20)&nbsp;hours per week (or such lesser period of time as may be determined by the Administrator in its discretion), (iii) customarily works not more than five&nbsp;(5) months per calendar year (or
such lesser period of time as may be determined by the Administrator in its discretion), (iv)&nbsp;is a highly compensated employee within the meaning of Section&nbsp;414(q) of the Code, or (v)&nbsp;is a highly compensated employee within the
meaning of Section&nbsp;414(q) of the Code with compensation above a certain level or is an officer or subject to the disclosure requirements of Section&nbsp;16(a) of the Exchange Act, provided the exclusion is applied with respect to each Offering
under the 423 Component in an identical manner to all highly compensated individuals of the Employer whose employees are participating in that Offering. Such exclusions may be applied with respect to an Offering under a 423 Component in a manner
complying with U.S. Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2(e)(2)(ii).</FONT> Such exclusions may be applied with respect to an Offering under the <FONT STYLE="white-space:nowrap">Non-</FONT> 423 Component without
regard to the limitations of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o)
&#147;<U>Employer</U>&#148; means the employer of an Eligible Employee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) &#147;<U>Enrollment Date</U>&#148; means the first Trading
Day of each Offering Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) &#147;<U>Exchange Act</U>&#148; means the U.S. Securities Exchange Act of 1934, as amended, including
the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) &#147;<U>Exercise Date</U>&#148; means such dates on which each outstanding option
granted under the Plan will be exercised (except if the Plan has been terminated), as may be determined by the Administrator, in its discretion and on a uniform and nondiscriminatory basis from time to time prior to an Enrollment Date for all
options to be granted on such Enrollment Date. Unless otherwise determined by the Administrator, each Exercise Date will be the last day of the applicable Offering Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) &#147;<U>Fair Market Value</U>&#148; means, as of any date and unless the Administrator determines otherwise, the value of Common Stock
determined as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) If the Common Stock is listed on any established stock exchange or national market system (including without
limitation the New York Stock Exchange, NASDAQ Global Select Market, the NASDAQ Global Market or the NASDAQ Capital Market of The NASDAQ Stock Market), the Fair Market Value will be the closing sales price for Common Stock (or the closing bid, if no
sales were reported) as quoted on such exchange or system on the date of determination, as reported in <I>The Wall Street Journal</I> or such other source as the Administrator deems reliable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value of
a share of Common Stock will be the mean between the high bid and low asked prices for the Common Stock on the day of determination (or, if no bids and asks were reported on that date, as applicable, on the last trading date such bids and asks were
reported), as reported in <I>The Wall Street Journal</I> or such other source as the Administrator deems reliable; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) In the
absence of an established market for the Common Stock, the Fair Market Value thereof will be determined in good faith by the Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
determination of fair market value for purposes of tax withholding may be made in the Administrator&#146;s discretion subject to Applicable Laws and is not required to be consistent with the determination of Fair Market Value for other purposes.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) &#147;<U>Fiscal Year</U>&#148; means the fiscal year of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) &#147;<U>New Exercise Date</U>&#148; means a new Exercise Date if the Administrator shortens any Offering Period then in progress. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) &#147;<U>Offering</U>&#148; means an offer under the Plan of an option that may be exercised during an Offering Period as further
described in Section&nbsp;4. For purposes of the Plan, the Administrator may designate separate Offerings under the Plan (the terms of which need not be identical) in which Eligible Employees of one or more Employers will participate, even if the
dates of the applicable Offering Periods of each such Offering are identical and the provisions of the Plan will separately apply to each Offering. If an Offering under the 423 Component is made, to the extent permitted by U.S. Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.423-2(a)(1),</FONT> the terms of each Offering need not be identical provided that the terms of the Plan and an Offering together satisfy U.S. Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2(a)(2)</FONT> and&nbsp;(a)(3). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w) &#147;<U>Offering Periods</U>&#148; means the periods during which shares of Common
Stock may be purchased under the Plan. The duration and timing of Offering Periods may be changed pursuant to Sections&nbsp;4, 19 and 29. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) &#147;<U>Parent</U>&#148; means a &#147;parent corporation,&#148; whether now or hereafter existing, as defined in Section&nbsp;424(e) of
the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y) &#147;<U>Participant</U>&#148; means an Eligible Employee that participates in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z) &#147;<U>Plan</U>&#148; means this Viracta Therapeutics, Inc. 2022 Employee Stock Purchase Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa) &#147;<U>Purchase Period</U>&#148; means the period, as determined by the Administrator in its discretion and on a uniform and
nondiscriminatory basis from time to time prior to an Enrollment Date for all options to be granted on such Enrollment Date, commencing on the Enrollment Date and ending with the next Exercise Date, except that if the Administrator determines that
more than one Purchase Period should occur within an Offering Period, subsequent Purchase Periods within such Offering Period commence after one Exercise Date and end with the next Exercise Date at such time or times as the Administrator determines
prior to the commencement of the applicable Offering Period. Unless otherwise determined by the Administrator, a Purchase Period shall have the same duration as the Offering Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb) &#147;<U>Purchase Price</U>&#148; means the price per share of Common Stock purchased under an option granted under the Plan as
determined by the Administrator from time to time, in its discretion and on a uniform and nondiscriminatory basis for all options to be granted on an Enrollment Date, subject to compliance with Section&nbsp;423 of the Code (or any successor rule or
provision or any other Applicable Law, regulation or stock exchange rule) or pursuant to Section&nbsp;19. However, in no event will the Purchase Price be less than eighty-five percent (85%) of the lower of the Fair Market Value of a share of Common
Stock on the Enrollment Date or the Fair Market Value of a share of Common Stock on the Exercise Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc)
&#147;<U>Section</U><U></U><U>&nbsp;409A</U>&#148; means Code Section&nbsp;409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and Internal Revenue Service guidance that has been promulgated or
may be promulgated thereunder from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd) &#147;<U>Subsidiary</U>&#148; means a &#147;subsidiary corporation,&#148; whether
now or hereafter existing, as defined in Section&nbsp;424(f) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ee) &#147;<U>Trading Day</U>&#148; means a day on which the
national stock exchange upon which the Common Stock is listed is open for trading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ff) &#147;<U>U.S. Treasury Regulations</U>&#148;
means the Treasury regulations of the Code. Reference to a specific Treasury Regulation or Section of the Code shall include such Treasury Regulation or Section, any valid regulation promulgated under such Section, and any comparable provision of
any future legislation or regulation amending, supplementing or superseding such Section or regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Eligibility</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Generally</U>. Any Eligible Employee on a given Enrollment Date will be eligible to participate in the Plan, subject to the
requirements of Section&nbsp;5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Employees</U>. Eligible Employees who are
citizens or residents of a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction (without regard to whether they also are citizens or residents of the United States or resident aliens (within the meaning of Section&nbsp;7701(b)(1)(A) of the
Code)) may be excluded from participation in the Plan or an Offering if the participation of such Eligible Employees is prohibited under the laws of the applicable jurisdiction or if complying with the laws of the applicable jurisdiction would cause
the Plan or an Offering to violate Section&nbsp;423 of the Code. In the case of the <FONT STYLE="white-space:nowrap">Non-423</FONT> Component, an Eligible Employee may be excluded from participation in the Plan or an Offering at the discretion of
the Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>423 Component Limitations</U>. Any provisions of the Plan to the contrary notwithstanding, with respect to any
Offering under the 423 Component, no Eligible Employee will be granted an option under the Plan (i)&nbsp;to the extent that, immediately after the grant, such Eligible Employee (or any other person whose stock would be attributed to such Eligible
Employee pursuant to Section&nbsp;424(d) of the Code) would own capital stock of the Company or any Parent or Subsidiary of the Company and/or hold outstanding options to purchase such stock possessing five percent (5%) or more of the total combined
voting power or value of all classes of the capital stock of the Company or of any Parent or Subsidiary of the Company, or (ii)&nbsp;to the extent that his or her rights to purchase stock under all employee stock purchase plans (as defined in
Section&nbsp;423 of the Code) of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company or any Parent or Subsidiary of the Company accrues at a rate that exceeds twenty-five thousand dollars ($25,000) worth of stock (determined at the Fair Market Value of the stock at the
time such option is granted) for each calendar year in which such option is outstanding at any time, as determined in accordance with Section&nbsp;423 of the Code and the regulations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Offering Periods</U>. The Plan will be implemented by consecutive Offering Periods with a new Offering Period commencing on the first
Trading Day on or after June&nbsp;1 and December&nbsp;1 each year and ending on the first Trading Day on or after December&nbsp;1 or June&nbsp;1, approximately six (6)&nbsp;months later, or on such other date as the Administrator will determine,
provided that the first Offering Period under the Plan shall begin on July&nbsp;1, 2022, and end on December&nbsp;1, 2022. The Administrator will have the power to change the duration of Offering Periods (including the commencement dates thereof)
with respect to future Offerings without stockholder approval if such change is announced prior to the scheduled beginning of the first Offering Period to be affected thereafter; provided, however, that no Offering Period may last more than
twenty-seven (27)&nbsp;months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Participation</U>. An Eligible Employee may participate in the Plan pursuant to Section&nbsp;3 by
(i)&nbsp;submitting to the Company&#146;s stock administration office (or its designee) a properly completed subscription agreement authorizing Contributions in the form provided by the Administrator for such purpose, or (ii)&nbsp;following an
electronic or other enrollment procedure determined by the Administrator, in either case, on or before a date determined by the Administrator prior to an applicable Enrollment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Contributions</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
At the time a Participant enrolls in the Plan pursuant to Section&nbsp;5, he or she will elect to have a fixed amount of Contributions (in the form of payroll deductions or otherwise, to the extent permitted by the Administrator) made during each
Purchase Period during the Offering Period (such fixed amount, the &#147;Elected Contribution Amount&#148;), provided that the Elected Contribution Amount will not exceed fifteen (15%) of the Compensation which a Participant receives during a
Purchase Period, or such other limit established by the Administrator from time to time in its discretion and on a uniform and nondiscretionary basis for all options to be granted on an Enrollment Date in an Offering. Except to the extent otherwise
permitted by the Administrator, Contributions will be deducted in equal installments from a Participant&#146;s payroll during each Purchase Period up to the Elected Contribution Amount (for illustrative purposes, a payroll deduction occurring on an
Exercise Date will be applied to a Participant&#146;s account under the Purchase Period ending on such Exercise Date). The Administrator, in its sole discretion, may permit all Participants in a specified Offering to contribute amounts to the Plan
through payment by cash, check, wire transfer or other means set forth in the subscription agreement or approved in writing by the Administrator prior to each Exercise Date of each Purchase Period. A Participant&#146;s subscription agreement will
remain in effect for successive Offering Periods unless terminated as provided in Section&nbsp;10 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event Contributions
are made in the form of payroll deductions, such payroll deductions for a Participant will commence on the first pay day following the Enrollment Date and will end on the last pay day on or prior to the Exercise Date of such Offering Period to which
such authorization is applicable, unless sooner terminated by the Participant as provided in Section&nbsp;10 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) All
Contributions made for a Participant will be credited to his or her account under the Plan and Contributions will be made in whole percentages of his or her Compensation only. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) A Participant may discontinue his or her participation in the Plan as provided in Section&nbsp;10. Except as may be permitted by the
Administrator, as determined in its sole discretion, a Participant may reduce, but may not increase, the Participant&#146;s Elected Contribution Amount up to one (1)&nbsp;times during an Offering Period by providing written notice to the Company
(which may be similar to the form attached hereto as <U>Exhibit B</U>). If a Participant elects to reduce his or her Elected Contribution Amount during an Offering Period, all payroll deductions occurring after such election will be reduced
prospectively to account for the new Elected Contribution Account. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding the foregoing, to the extent necessary to comply
with Section&nbsp;423(b)(8) of the Code and Section&nbsp;3(c), a Participant&#146;s Elected Contribution Amount may be decreased to zero percent (0%) at any time during a Purchase Period. To the extent necessary, and subject to
Section&nbsp;423(b)(8) of the Code and Section&nbsp;3(c) hereof, Contributions will recommence pursuant to the Elected Contribution Amount originally elected by the Participant effective as of the beginning of the first Purchase Period scheduled to
end in the following calendar year, unless terminated by the Participant as provided in Section&nbsp;10. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding any
provisions or limits to the contrary in the Plan, the Administrator may allow Eligible Employees to participate in the Plan via cash contributions or other methods instead of payroll deductions if (i)&nbsp;payroll deductions are not permitted under
applicable local law, (ii)&nbsp;the Administrator determines that cash contributions are permissible under Section&nbsp;423 of the Code or (iii)&nbsp;for Participants participating in the <FONT STYLE="white-space:nowrap">Non-423</FONT> Component.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) At the time the option is exercised, in whole or in part, or at the time some or all of
the Common Stock issued under the Plan is disposed of (or any other time that a taxable event related to the Plan occurs), the Participant must make adequate provision for the Company&#146;s or Employer&#146;s federal, state, local or any other tax
liability payable to any authority including taxes imposed by jurisdictions outside of the U.S., national insurance, social security or other tax withholding obligations, if any, which arise upon the exercise of the option or the disposition of the
Common Stock (or any other time that a taxable event related to the Plan occurs). At any time, the Company or the Employer may, but will not be obligated to, withhold from the Participant&#146;s compensation the amount necessary for the Company or
the Employer to meet applicable withholding obligations, including any withholding required to make available to the Company or the Employer any tax deductions or benefits attributable to sale or early disposition of Common Stock by the Eligible
Employee. In addition, the Company or the Employer may, but will not be obligated to, withhold from the proceeds of the sale of Common Stock or any other method of withholding the Company or the Employer deems appropriate to the extent permitted by
U.S. Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2(f).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Grant of Option</U>. On the Enrollment
Date of each Offering Period, each Eligible Employee participating in such Offering Period will be granted an option to purchase on each Exercise Date during such Offering Period (at the applicable Purchase Price) up to a number of shares of Common
Stock determined by dividing such Eligible Employee&#146;s Contributions accumulated prior to such Exercise Date and retained in the Eligible Employee&#146;s account as of the Exercise Date by the applicable Purchase Price; provided that in no event
will an Eligible Employee be permitted to purchase under the Plan during each Purchase Period more than 10,000 shares of Common Stock (subject to any adjustment pursuant to Section&nbsp;18) and provided further that such purchase will be subject to
the limitations set forth in Sections 3(c) and 13. The Eligible Employee may accept the grant of such option by electing to participate in the Plan in accordance with the requirements of Section&nbsp;5. The Administrator may, for future Offering
Periods, increase or decrease, in its absolute discretion, the maximum number of shares of Common Stock that an Eligible Employee may purchase during each Purchase Period of an Offering Period. Exercise of the option will occur as provided in
Section&nbsp;8, unless the Participant has withdrawn pursuant to Section&nbsp;10 (or Participant&#146;s participation is terminated as provided in Section&nbsp;11). The option will expire on the last day of the Offering Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Exercise of Option</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Unless a Participant withdraws from the Plan as provided in Section&nbsp;10 (or Participant&#146;s participation is terminated as provided
in Section&nbsp;11), his or her option for the purchase of shares of Common Stock will be exercised automatically on the Exercise Date, and the maximum number of full shares subject to the option will be purchased for such Participant at the
applicable Purchase Price with the accumulated Contributions from his or her account. No fractional shares of Common Stock will be purchased; unless otherwise determined by the Administrator, any Contributions accumulated in a Participant&#146;s
account, which are not sufficient to purchase a full share will be retained in the Participant&#146;s account for the subsequent Purchase Period or Offering Period, subject to earlier withdrawal by the Participant as provided in Section&nbsp;10. Any
other funds left over in a Participant&#146;s account after the Exercise Date will be returned to the Participant. During a Participant&#146;s lifetime, a Participant&#146;s option to purchase shares of Common Stock hereunder is exercisable only by
him or her. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the Administrator determines that, on a given Exercise Date, the number of shares of Common Stock with respect to
which options are to be exercised may exceed (i)&nbsp;the number of shares of Common Stock that were available for sale under the Plan on the Enrollment Date of the applicable Offering Period, or (ii)&nbsp;the number of shares of Common Stock
available for sale under the Plan on such Exercise Date, the Administrator may in its sole discretion (x)&nbsp;provide that the Company will make a pro rata allocation of the shares of Common Stock available for purchase on such Enrollment Date or
Exercise Date, as applicable, in as uniform a manner as will be practicable and as it will determine in its sole discretion to be equitable among all Participants exercising options to purchase Common Stock on such Exercise Date, and continue all
Offering Periods then in effect or (y)&nbsp;provide that the Company will make a pro rata allocation of the shares of Common Stock available for purchase on such Enrollment Date or Exercise Date, as applicable, in as uniform a manner as will be
practicable and as it will determine in its sole discretion to be equitable among all participants exercising options to purchase Common Stock on such Exercise Date, and terminate any or all Offering Periods then in effect pursuant to
Section&nbsp;19. The Company may make a pro rata allocation of the shares available on the Enrollment Date of any applicable Offering Period pursuant to the preceding sentence, notwithstanding any authorization of additional shares for issuance
under the Plan by the Company&#146;s stockholders subsequent to such Enrollment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Delivery</U>. As soon as reasonably
practicable after each Exercise Date on which a purchase of shares of Common Stock occurs, the Company will arrange the delivery to each Participant of the shares of Common Stock purchased upon exercise of his or her option in a form determined by
the Administrator (in its sole discretion) and pursuant to rules established by the Administrator. The Company may permit or require that shares of Common Stock be deposited directly with a broker designated by the Company or to a designated agent
of the Company, and the Company may utilize electronic or automated methods of share transfer. The Company may require that shares of Common Stock be retained with such broker or agent for a designated period of time and/or may establish other
procedures to permit tracking of disqualifying dispositions of such shares. No Participant will have any voting, dividend, or other stockholder rights with respect to shares of Common Stock subject to any option granted under the Plan until such
shares have been purchased and delivered to the Participant as provided in this Section&nbsp;9. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Withdrawal</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) A Participant may withdraw all but not less than all the Contributions credited to his or her account and not yet used to exercise his or
her option under the Plan at any time by (i)&nbsp;submitting to the Company&#146;s stock administration office (or its designee) a written notice of withdrawal in the form determined by the Administrator for such purpose (which may be similar to the
form attached hereto as <U>Exhibit B</U>), or (ii)&nbsp;following an electronic or other withdrawal procedure determined by the Administrator. The Administrator may set forth a deadline of when a withdrawal must occur to be effective prior to a
given Exercise Date in accordance with policies it may approve from time to time. All of the Participant&#146;s Contributions credited to his or her account will be paid to such Participant as soon as administratively practicable after receipt of
notice of withdrawal and such Participant&#146;s option for the Offering Period will be automatically terminated, and no further Contributions for the purchase of shares will be made for such Offering Period. If a Participant withdraws from an
Offering Period, Contributions will not resume at the beginning of the succeeding Offering Period, unless the Participant <FONT STYLE="white-space:nowrap">re-enrolls</FONT> in the Plan in accordance with the provisions of Section&nbsp;5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) A Participant&#146;s withdrawal from an Offering Period will not have any effect upon his or her eligibility to participate in any similar
plan that may hereafter be adopted by the Company or in succeeding Offering Periods that commence after the termination of the Offering Period from which the Participant withdraws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.</B> <U>Termination of Employment</U>. Upon a Participant&#146;s ceasing to be an Eligible Employee for any reason, he or she will be
deemed to have elected to withdraw from the Plan and the Contributions credited to such Participant&#146;s account during the Offering Period but not yet used to purchase shares of Common Stock under the Plan will be returned to such Participant or,
in the case of his or her death, to the person or persons entitled thereto under Section&nbsp;15, and such Participant&#146;s option will be automatically terminated. Unless determined otherwise by the Administrator in a manner that, with respect to
an Offering under the 423 Component, is permitted by, and compliant with, Section&nbsp;423 of the Code, a Participant whose employment transfers between entities through a termination with an immediate rehire (with no break in service) by the
Company or a Designated Company shall not be treated as terminated under the Plan; however, no Participant shall be deemed to switch from an Offering under the <FONT STYLE="white-space:nowrap">Non-423</FONT> Component to an Offering under the 423
Component or vice versa unless (and then only to the extent) such switch would not cause the 423 Component or any option thereunder to fail to comply with Section&nbsp;423 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Interest</U>. No interest will accrue on the Contributions of a participant in the Plan, except as may be required by Applicable Law,
as determined by the Company, and if so required by the laws of a particular jurisdiction, shall, with respect to Offerings under the 423 Component, apply to all Participants in the relevant Offering, except to the extent otherwise permitted by U.S.
Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2(f).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to adjustment upon changes in capitalization of the Company as provided in Section&nbsp;18 hereof, the maximum number of shares of
Common Stock that will be made available for sale under the Plan will be 500,000 shares of Common Stock, plus the number of shares of Common Stock to be added to the Plan pursuant to the next sentence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The number of shares of Common Stock available for issuance under the Plan will be increased on the first day of each Fiscal Year
beginning with the 2023 Fiscal Year equal to the least of (i)&nbsp;500,000 shares of Common Stock, (ii)&nbsp;one percent (1)% of the outstanding shares of all classes of common stock of the Company on the last day of the immediately preceding Fiscal
Year, or (iii)&nbsp;an amount determined by the Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Until the shares of Common Stock are issued (as evidenced by the
appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), a Participant will have only the rights of an unsecured creditor with respect to such shares, and no right to vote or receive dividends or any
other rights as a stockholder will exist with respect to such shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Shares of Common Stock to be delivered to a Participant under
the Plan will be registered in the name of the Participant or, if so required under Applicable Laws, in the name of the Participant and his or her spouse. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Administration</U>. The Plan will be administered by the Board or a Committee appointed by the Board, which Committee will be
constituted to comply with Applicable Laws. To the extent permitted by Applicable Laws, the Administrator will have full and exclusive discretionary authority to construe, interpret and apply the terms of the Plan, to delegate ministerial duties to
any of the Company&#146;s employees, to designate separate Offerings under the Plan, to designate Subsidiaries and Affiliates as participating in the 423 Component or <FONT STYLE="white-space:nowrap">Non-423</FONT> Component, to determine
eligibility, to adjudicate all disputed claims filed under the Plan and to establish such procedures that it deems necessary or advisable for the administration of the Plan (including, without </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 7 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
limitation, to adopt such procedures and <FONT STYLE="white-space:nowrap">sub-plans</FONT> as are necessary or appropriate to permit the participation in the Plan by employees who are <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> nationals or employed outside the U.S., the terms of which <FONT STYLE="white-space:nowrap">sub-plans</FONT> may take precedence over other provisions of this Plan, with the exception of Section&nbsp;13(a)
hereof, but unless otherwise superseded by the terms of such <FONT STYLE="white-space:nowrap">sub-plan,</FONT> the provisions of this Plan shall govern the operation of such <FONT STYLE="white-space:nowrap">sub-plan).</FONT> Unless otherwise
determined by the Administrator, the employees eligible to participate in each <FONT STYLE="white-space:nowrap">sub-plan</FONT> will participate in a separate Offering and will be in the <FONT STYLE="white-space:nowrap">Non-423</FONT> Component
unless such designation would cause the 423 Component to violate the requirements of Section&nbsp;423 of the Code. Without limiting the generality of the foregoing, the Administrator is specifically authorized to adopt rules and procedures regarding
eligibility to participate, the definition of Compensation, handling of Contributions, making of Contributions to the Plan (including, without limitation, in forms other than payroll deductions), establishment of bank or trust accounts to hold
Contributions, payment of interest, conversion of local currency, obligations to pay payroll tax, determination of beneficiary designation requirements, withholding procedures and handling of stock certificates that vary with applicable local
requirements. The Administrator also is authorized to determine that, to the extent permitted by U.S. Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2(f),</FONT> the terms of an option granted under the Plan or an Offering
to citizens or residents of a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction will be less favorable than the terms of options granted under the Plan or the same Offering to employees resident solely in the U.S. Every finding, decision
and determination made by the Administrator will, to the full extent permitted by law, be final and binding upon all parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.
<U>Designation of Beneficiary</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If permitted by the Administrator, a Participant may file a designation of a beneficiary who is to
receive any shares of Common Stock and cash, if any, from the Participant&#146;s account under the Plan in the event of such Participant&#146;s death subsequent to an Exercise Date on which the option is exercised but prior to delivery to such
Participant of such shares and cash. In addition, if permitted by the Administrator, a Participant may file a designation of a beneficiary who is to receive any cash from the Participant&#146;s account under the Plan in the event of such
Participant&#146;s death prior to exercise of the option. If a Participant is married and the designated beneficiary is not the spouse, spousal consent will be required for such designation to be effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Such designation of beneficiary may be changed by the Participant at any time by notice in a form determined by the Administrator. In the
event of the death of a Participant and in the absence of a beneficiary validly designated under the Plan who is living at the time of such Participant&#146;s death, the Company will deliver such shares and/or cash to the executor or administrator
of the estate of the Participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may deliver such shares and/or cash to the spouse or to any one or more dependents or
relatives of the Participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) All beneficiary designations will be in such form and manner as the Administrator may designate from time to time. Notwithstanding
Sections 15(a) and (b)&nbsp;above, the Company and/or the Administrator may decide not to permit such designations by Participants in <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions to the extent permitted by U.S. Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.423-2(f).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Transferability</U>. Neither Contributions credited to a
Participant&#146;s account nor any rights with regard to the exercise of an option or to receive shares of Common Stock under the Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent
and distribution or as provided in Section&nbsp;15 hereof) by the Participant. Any such attempt at assignment, transfer, pledge or other disposition will be without effect, except that the Company may treat such act as an election to withdraw funds
from an Offering Period in accordance with Section&nbsp;10 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Use of Funds</U>. The Company may use all Contributions
received or held by it under the Plan for any corporate purpose, and the Company will not be obligated to segregate such Contributions except under Offerings or for Participants in the <FONT STYLE="white-space:nowrap">Non-423</FONT> Component for
which Applicable Laws require that Contributions to the Plan by Participants be segregated from the Company&#146;s or the Employer&#146;s general corporate funds and/or deposited with an independent third party. Until shares of Common Stock are
issued, Participants will only have the rights of an unsecured creditor with respect to such shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Adjustments, Dissolution,
Liquidation, Merger or Change in Control</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Adjustments</U>. In the event that any dividend or other distribution (whether in
the form of cash, Common Stock, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, <FONT STYLE="white-space:nowrap">split-up,</FONT>
<FONT STYLE="white-space:nowrap">spin-off,</FONT> combination, reclassification, repurchase, or exchange of Common Stock or other securities of the Company, or other change in the corporate structure of the Company affecting the Common Stock occurs
(other than any ordinary dividends or other ordinary distributions), the Administrator, in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan, will, in such manner as it may
deem equitable, adjust the number and class of Common Stock that may be delivered under the Plan, the Purchase Price per share, the class, and the number of shares of Common Stock covered by each option under the Plan that has not yet been
exercised, and the numerical limits of Sections 7 and 13. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 8 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Dissolution or Liquidation</U>. In the event of the proposed dissolution or
liquidation of the Company, any Offering Period then in progress will be shortened by setting a New Exercise Date, and will terminate immediately prior to the consummation of such proposed dissolution or liquidation, unless provided otherwise by the
Administrator. The New Exercise Date will be before the date of the Company&#146;s proposed dissolution or liquidation. The Administrator will notify each Participant in writing or electronically, prior to the New Exercise Date, that the Exercise
Date for the Participant&#146;s option has been changed to the New Exercise Date and that the Participant&#146;s option will be exercised automatically on the New Exercise Date, unless prior to such date the Participant has withdrawn from the
Offering Period as provided in Section&nbsp;10 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Merger or Change in Control</U>. In the event of a merger or Change in
Control, each outstanding option will be assumed or an equivalent option substituted by the successor corporation or a Parent or Subsidiary of the successor corporation. In the event that the successor corporation refuses to assume or substitute for
the option, the Offering Period with respect to which such option relates will be shortened by setting a New Exercise Date on which such Offering Period shall end. The New Exercise Date will occur before the date of the Company&#146;s proposed
merger or Change in Control. The Administrator will notify each Participant in writing or electronically prior to the New Exercise Date, that the Exercise Date for the Participant&#146;s option has been changed to the New Exercise Date and that the
Participant&#146;s option will be exercised automatically on the New Exercise Date, unless prior to such date the Participant has withdrawn from the Offering Period as provided in Section&nbsp;10 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Amendment or Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Administrator, in its sole discretion, may amend, suspend, or terminate the Plan, or any part thereof, at any time and for any reason.
If the Plan is terminated, the Administrator, in its discretion, may elect to terminate all outstanding Offering Periods either immediately or upon completion of the purchase of shares of Common Stock on the next Exercise Date (which may be sooner
than originally scheduled, if determined by the Administrator in its discretion), or may elect to permit Offering Periods to expire in accordance with their terms (and subject to any adjustment pursuant to Section&nbsp;18). If the Offering Periods
are terminated prior to expiration, all amounts then credited to Participants&#146; accounts that have not been used to purchase shares of Common Stock will be returned to the Participants (without interest thereon, except as otherwise required
under Applicable Laws, as further set forth in Section&nbsp;12 hereof) as soon as administratively practicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without stockholder
consent and without limiting Section&nbsp;19(a), the Administrator will be entitled to change the Offering Periods or Purchase Periods, designate separate Offerings, limit the frequency and/or number of changes in the amount withheld during an
Offering Period, establish the exchange ratio applicable to amounts withheld in a currency other than U.S. dollars, permit Contributions in excess of the amount designated by a Participant in order to adjust for delays or mistakes in the
Company&#146;s processing of properly completed Contribution elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of Common Stock for each
Participant properly correspond with Contribution amounts, and establish such other limitations or procedures as the Administrator determines in its sole discretion advisable that are consistent with the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In the event the Administrator determines that the ongoing operation of the Plan may result in unfavorable financial accounting
consequences, the Administrator may, in its discretion and, to the extent necessary or desirable, modify, amend or terminate the Plan to reduce or eliminate such accounting consequence, including, but not limited to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) amending the Plan to conform with the safe harbor definition under the Financial Accounting Standards Board Accounting Standards
Codification Topic 718 (or any successor thereto), including with respect to an Offering Period underway at the time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) altering the
Purchase Price for any Offering Period or Purchase Period including an Offering Period or Purchase Period underway at the time of the change in Purchase Price, but, with respect to any existing Offerings under the 423 Component, in no event below
the lowest Purchase Price permitted by Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2(g);</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)
shortening any Offering Period or Purchase Period by setting a New Exercise Date, including an Offering Period or Purchase Period underway at the time of the Administrator action; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) reducing the maximum Elected Contribution Amount a Participant may elect; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) reducing the maximum number of shares of Common Stock a Participant may purchase during any Offering Period or Purchase Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 9 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) Such modifications or amendments will not require stockholder approval or the consent of any Plan
Participants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Notices</U>. All notices or other communications by a Participant to the Company under or in connection with the
Plan will be deemed to have been duly given when received in the form and manner specified by the Company at the location, or by the person, designated by the Company for the receipt thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Conditions Upon Issuance of Shares</U>. Shares of Common Stock will not be issued with respect to an option unless the exercise of such
option and the issuance and delivery of such shares pursuant thereto will comply with all applicable provisions of law, domestic or foreign, including, without limitation, the Securities Act of 1933, as amended, the Exchange Act, the rules and
regulations promulgated thereunder, and the requirements of any stock exchange upon which the shares may then be listed, and will be further subject to the approval of counsel for the Company with respect to such compliance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As a condition to the exercise of an option, the Company may require the person exercising such option to represent and warrant at the time of
any such exercise that the shares are being purchased only for investment and without any present intention to sell or distribute such shares if, in the opinion of counsel for the Company, such a representation is required by any of the
aforementioned applicable provisions of law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>Code Section</U><U></U><U>&nbsp;409A.</U> The 423 Component of the Plan is exempt
from the application of Code Section&nbsp;409A and any ambiguities herein will be interpreted to so be exempt from Code Section&nbsp;409A. The <FONT STYLE="white-space:nowrap">Non-423</FONT> Component is intended to be exempt from the application of
Code Section&nbsp;409A as options granted thereunder are intended to constitute &#147;short term deferrals&#148; and any ambiguities herein will be interpreted such that those options shall so be exempt from Code Section&nbsp;409A. In furtherance of
the foregoing and notwithstanding any provision in the Plan to the contrary, if the Administrator determines that an option granted under the Plan may be subject to Code Section&nbsp;409A or that any provision in the Plan would cause an option under
the Plan to be subject to Code Section&nbsp;409A, the Administrator may amend the terms of the Plan and/or of an outstanding option granted under the Plan, or take such other action the Administrator determines is necessary or appropriate, in each
case, without the Participant&#146;s consent, to exempt any outstanding option or future option that may be granted under the Plan from or to allow any such options to comply with Code Section&nbsp;409A, but only to the extent any such amendments or
action by the Administrator would not violate Code Section&nbsp;409A. Notwithstanding the foregoing, the Company and any of its Parent or Subsidiaries shall have no obligation to reimburse, indemnify, or hold harmless a Participant or any other
party if the option to purchase Common Stock under the Plan that is intended to be exempt from or compliant with Section&nbsp;409A is not so exempt or compliant or for any action taken by the Administrator with respect thereto. The Company makes no
representation that the option to purchase Common Stock under the Plan is compliant with Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. <U>Term of Plan</U>. The
Plan will become effective upon the earlier to occur of its adoption by the Board or its approval by the stockholders of the Company. Unless sooner terminated under Section&nbsp;19, the Plan will continue in effect for a term of twenty
(20)&nbsp;years from the date the Plan is adopted by the Board and Section&nbsp;13(b) will operate only until the date that is ten (10)&nbsp;years from the date the Plan is adopted by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. <U>Stockholder Approval</U>. The Plan will be subject to approval by the stockholders of the Company within twelve (12)&nbsp;months after
the date the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required under Applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25. <U>Automatic Transfer to Low Price Offering Period</U>. Unless the Administrator, in its sole discretion, chooses otherwise prior to an
Enrollment Date, and to the extent permitted by Applicable Laws, if the Fair Market Value of the Common Stock on any Exercise Date in an Offering Period is lower than the Fair Market Value of the Common Stock on the Enrollment Date of such Offering
Period, then all participants in such Offering Period automatically will be withdrawn from such Offering Period immediately after the exercise of their option on such Exercise Date and automatically
<FONT STYLE="white-space:nowrap">re-enrolled</FONT> in the immediately following Offering Period as of the first day thereof and the preceding Offering Period will terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26. <U>Governing Law</U>. The Plan shall be governed by, and construed in accordance with, the laws of the State of Delaware (except its <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">choice-of-law</FONT></FONT> provisions). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27. <U>No Right to Employment</U>.
Participation in the Plan by a Participant shall not be construed as giving a Participant the right to be retained as an employee of the Company or a Subsidiary or Affiliate, as applicable. Furthermore, the Company or a Subsidiary or Affiliate may
dismiss a Participant from employment at any time, free from any liability or any claim under the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 10 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">28. <U>Severability</U>. If any provision of the Plan is or becomes or is deemed to be
invalid, illegal, or unenforceable for any reason in any jurisdiction or as to any Participant, such invalidity, illegality or unenforceability shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as to such
jurisdiction or Participant as if the invalid, illegal or unenforceable provision had not been included. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29. <U>Compliance with
Applicable Laws</U>. The terms of this Plan are intended to comply with all Applicable Laws and will be construed accordingly. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 11 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VIRACTA THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2022 EMPLOYEE STOCK PURCHASE PLAN </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUBSCRIPTION AGREEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>Original Application</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Offering Date:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">_____ Change in Elected Contribution Amount</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Capitalized terms used but not otherwise defined herein shall have the meaning given to such terms in the Viracta
Therapeutics, Inc. 2022 Employee Stock Purchase Plan. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. ____________________ hereby elects to participate in the Viracta
Therapeutics, Inc. 2022 Employee Stock Purchase Plan (the &#147;Plan&#148;) and subscribes to purchase shares of the Company&#146;s Common Stock in accordance with this 2022 Employee Stock Purchase Plan Subscription Agreement (the &#147;Subscription
Agreement&#148;) and the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. I hereby authorize an Elected Contribution Amount during each Purchase Period of $___________. I
understand that, except to the extent otherwise permitted by the Administrator, Contributions will be deducted in equal installments from my payroll during each Purchase Period up to my Elected Contribution Amount. I further understand that my
Elected Contribution Amount will not exceed fifteen (15)% of the Compensation which I receive during a Purchase Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. I hereby
authorize the Company and/or my Employer to sell shares of Common Stock acquired pursuant to an Offering under the Plan that are necessary to satisfy any <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items legally payable by me, as specified
in Section&nbsp;7 of this Subscription Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. I understand that Contributions in the form of payroll deductions will be
accumulated for the purchase of shares of Common Stock at the applicable Purchase Price determined in accordance with the Plan. I understand that if I do not withdraw from an Offering Period, any accumulated payroll deductions will be used to
automatically exercise my option and purchase Common Stock under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. I have received a copy of the complete Plan and its
accompanying prospectus. I understand that my participation in the Plan is in all respects subject to the terms of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. The
Company reserves the right to modify the Plan and to impose other requirements on my participation in the Plan, on the option and on any shares of Common Stock purchased under the Plan, to the extent the Company determines it is necessary or
advisable for legal or administrative reasons. I agree to be bound by such modifications regardless of whether notice is given to me of such event, subject, in any case, to my right to withdrawal from participation in the Plan. I further agree to
sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. It is understood that currently for
a U.S. taxpayer there is no tax event for the purchase of shares under the Plan. If the U.S. tax laws change or if the laws of my <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction result in a tax withholding obligation upon my purchase
of shares, then the issuance of such shares will be subject to me making satisfactory arrangements (as determined by the Administrator) for the payment of income, employment, social insurance, National Insurance Contributions, payroll tax, fringe
benefit tax, payment on account or other <FONT STYLE="white-space:nowrap">tax-related</FONT> items related to my participation in the Plan and legally applicable to me <FONT STYLE="white-space:nowrap">(&#147;Tax-Related</FONT> Items&#148;) that the
Administrator determines must be withheld. <I>I hereby specifically authorize the Company and/or my Employer to withhold any <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items from proceeds of the sale of shares of Common Stock acquired
pursuant to an Offering under the Plan through a sale arranged by the Company and I hereby authorize the Company and/or the Employer to withhold any <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items legally payable by me from proceeds of the
sale of shares of Common Stock on my behalf pursuant to this authorization without further consent</I>. In addition, the Company has the right (but not the obligation) to satisfy any <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items by
reducing the number of shares of </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Common Stock otherwise deliverable to me. If I do not arrange for the payment of any <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items the Company may refuse to deliver the shares to me.
If I am subject to taxation in more than one jurisdiction during an Offering Period, the Company and/or the Employer or former Employer may withhold or account for tax in greater than one jurisdiction. Regardless of any action of the Company or the
Employer, I acknowledge that the ultimate liability for all <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items is and remains my responsibility and may exceed the amount actually withheld by the Company or the Employer. I further acknowledge
that the Company and the Employer (1)&nbsp;make no representations or undertakings regarding the treatment of any <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items in connection with any aspect of my participation in the Plan; and
(2)&nbsp;do not commit to and are under no obligation to structure the terms of the Plan to reduce or eliminate my liability for <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items or achieve any particular tax result. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by
electronic means. I hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an <FONT STYLE="white-space:nowrap">on-line</FONT> or electronic system established and maintained by the Company or
another third party designated by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. The Subscription Agreement shall be governed by and construed in accordance with the
laws of the State of Delaware (without regard to its conflicts of law provisions) as such laws are applied to agreements between Delaware residents entered into and to be performed entirely within Delaware. For purposes of litigating any dispute
that arises directly or indirectly from the relationship of the parties, I hereby submit and consent to the exclusive jurisdiction of the State of Delaware and agree that such litigation shall be conducted only in the Delaware Court of Chancery or
the federal courts for the United States for the District of Delaware, and no other courts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. Notwithstanding any provision of this
Subscription Agreement, I understand that if I am working or resident in a country other than the United States, my participation in the Plan shall also be subject to the Additional Terms and Conditions for
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Employees set forth in <B>Appendix A </B>attached hereto and any special terms and conditions for my country set forth in <B>Appendix B </B>attached hereto. Further, I understand that if I relocate to
one of the countries included in Appendix B, the special terms and conditions for such country will apply to me to the extent the Company determines in its sole discretion that the application of such terms and conditions is necessary or advisable
for legal or administrative reasons. <B>Appendix A</B> and <B>Appendix B</B> constitute part of this Subscription Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. I hereby
agree to be bound by the terms of the Plan and this Subscription. The effectiveness of this Subscription Agreement is dependent upon my eligibility to participate in the Plan. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Employee&#146;s Social</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Security Number:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Employee&#146;s Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I ACKNOWLEDGE AND UNDERSTAND THAT THIS SUBSCRIPTION AGREEMENT INCLUDING ITS APPENDICES AND MY PARTICIPATION IN THE PLAN WILL
REMAIN IN EFFECT THROUGHOUT SUCCESSIVE OFFERING PERIODS UNLESS AFFIRMATIVELY TERMINATED BY ME. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dated:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Signature of Employee</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VIRACTA THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2022 EMPLOYEE STOCK PURCHASE PLAN </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF REDUCTION OF ELECTED CONTRIBUTION AMOUNT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OR </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WITHDRAWAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check Appropriate Box </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#9744;<B></B><B><U>Reduction of Elected
Contribution Amount.</U></B> The undersigned Participant in the Offering Period of the Viracta Therapeutics, Inc. 2022 Employee Stock Purchase Plan that began on ____________, ______ (the &#147;<U>Offering Date</U>&#148;) hereby notifies the Company
that he or she hereby wishes to reduce his or her Elected Contribution Amount to the following amount: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">$ _________ (the &#147;<U>Reduced
Elected Contribution Amount</U>&#148;) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned understands that all subsequent payroll deductions will be made pursuant to the Reduced Elected
Contribution Amount for the purchase of shares in the current Offering Period and for subsequent Offering Periods. The undersigned will be eligible to participate in succeeding Offering Periods at a higher rate of contribution only by delivering to
the Company a new Subscription Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B><B><U></U></B>&#9744;<B></B><B>Withdrawal.</B><B> </B>The undersigned Participant in the Offering Period
of Viracta Therapeutics, Inc. 2022&nbsp;Employee Stock Purchase Plan that began on ____________, ______ (the &#147;<U>Offering Date</U>&#148;) hereby notifies the Company that he or she hereby withdraws from the Offering Period. He or she hereby
directs the Company to pay to the undersigned as promptly as practicable all the payroll deductions credited to his or her account with respect to such Offering Period. The undersigned understands and agrees that his or her option for such Offering
Period will be terminated automatically. The undersigned understands further that no further payroll deductions will be made for the purchase of shares in the current Offering Period and the undersigned will be eligible to participate in succeeding
Offering Periods only by delivering to the Company a new Subscription Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name and Address of Participant:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Signature:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Date:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>virx-20220608.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 6/8/2022 10:41:37 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  xmlns:virx="http://viracta.com/20220608"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://viracta.com/20220608"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="virx-20220608_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="virx-20220608_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>virx-20220608_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 6/8/2022 10:41:37 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>virx-20220608_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 6/8/2022 10:41:37 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="virx-20220608.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139853513515992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 08, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001061027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  08,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VIRACTA THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3295878<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2533 S Coast Hwy 101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cardiff<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">400-8470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VIRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d311733d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="virx-20220608.xsd" xlink:type="simple"/>
    <context id="duration_2022-06-08_to_2022-06-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001061027</identifier>
        </entity>
        <period>
            <startDate>2022-06-08</startDate>
            <endDate>2022-06-08</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2022-06-08_to_2022-06-08">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-06-08_to_2022-06-08"
      id="Hidden_dei_EntityCentralIndexKey">0001061027</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-06-08_to_2022-06-08">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-06-08_to_2022-06-08">2022-06-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2022-06-08_to_2022-06-08">VIRACTA THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-06-08_to_2022-06-08">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-06-08_to_2022-06-08">000-51531</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-06-08_to_2022-06-08">94-3295878</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-06-08_to_2022-06-08">2533 S Coast Hwy 101</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2022-06-08_to_2022-06-08">Suite 210</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-06-08_to_2022-06-08">Cardiff</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-06-08_to_2022-06-08">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-06-08_to_2022-06-08">92007</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-06-08_to_2022-06-08">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-06-08_to_2022-06-08">400-8470</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-06-08_to_2022-06-08">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-06-08_to_2022-06-08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-06-08_to_2022-06-08">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-06-08_to_2022-06-08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-06-08_to_2022-06-08">Common Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-06-08_to_2022-06-08">VIRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-06-08_to_2022-06-08">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-06-08_to_2022-06-08">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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ML0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9
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M8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ O8#(5)E<G",0!@  G"<  !,
M             ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" "]@,A4]HWR.U($  #@$   &               @($."   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ O8#(5)^@&_"Q @  X@P   T
M             ( !E@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "]@,A4
MEXJ[',     3 @  "P              @ %R#P  7W)E;',O+G)E;'-02P$"
M% ,4    " "]@,A4'#AEZC\!   \ @  #P              @ %;$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ O8#(5"0>FZ*M    ^ $  !H
M         ( !QQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ O8#(5&60>9(9 0  SP,  !,              ( !K!(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ]A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d311733d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d311733d8k.htm">d311733d8k.htm</File>
    <File>d311733dex101.htm</File>
    <File>virx-20220608.xsd</File>
    <File>virx-20220608_lab.xml</File>
    <File>virx-20220608_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d311733d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d311733d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "virx-20220608_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "virx-20220608_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "virx-20220608.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "virx",
   "nsuri": "http://viracta.com/20220608",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d311733d8k.htm",
      "contextRef": "duration_2022-06-08_to_2022-06-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d311733d8k.htm",
      "contextRef": "duration_2022-06-08_to_2022-06-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://viracta.com//20220608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001193125-22-170177-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-170177-xbrl.zip
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M!.#*PS@4;<<![_& F& %HEI6IE\S% +AC8Z\PQ ;9]L@N"K5)CXK \,!X3)
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MVP/*7/(YI.@!?,EW\_CW8[Z1WPT5/JW"%A=RCFS/+2-;+M6RM9/*_F$QRR4
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MN*7ZM=Y84A2!LAKETXMBD8(4%44R4+"?T[JIYB 5=8E#@[G 65"X*?#_(I^
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MN@Z5JNVB(^0/;@+NLYVLZ#?B&Y13A9<H\?<*[G$A09TP!HKIY6?;K4BH'RD
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M'.><Z/;PQF.OHZS:*0*;BC!Q$'H&D1>7G.D6*AR3A:C%?M%H)'DIAGJ\M(2
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M-BL30J"DDET0&VX?$:.T][K.%0&0VG@B/W\R+P2Q: CW+ PC+-HE^YLVP01
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M:IIK(TS>EZ1*A19,Q!RDOVN?/'N-C>:P6@=345.JT?=N?9LPN-DBY/7*&6[
M%&!&7P20H'A])%H?*5SR?4D8N]O_A"QL.BS2,1>6@7%0(J5$9>.<$\,=F'-N
MC$UJC4]S.^OYP"G#%L\(AS9W>9#L31W-S4Z0]*^T_0ZYH5@C<VZN8>46_=[6
MWB,I(UW G)R.V",OI9+78>,'GAD>TI"0:K M #%**0GYY]PPF,J#^6Q@NYZM
MW;L,81.^\Q-+""VQF7W9V@Y:21?WL;X0T'G!2_E:%2!\6[M[LDYPVD"'<@\-
MOHW77"H*0$5C2GJDY<#O.ZUK(J8&PC'":C.'/R$*QMC$KCQEB)B&SB6Z !<'
M_@XN2DYC!!%::<YA0Q-K8KF&EV5)!,4&GF)[(TW[O: I9NHNX%JTGG+E_)KE
M5?(^JSZK)OD]*^8NP-*#2Z&XM'LQ1<I):TKO".CA1J^@<$:[F:D'(07M*2 -
M"CFT&K[J4IL6[M #/+H%MPY@,?I-%W-FF\H$W"*YZ4U6QKK(LJWA#F&-8B_3
M=TB-@L9#[I!LCZ\(U%)3IQFJ;HD'FJ"/):^.=OTQM\(FCAM7N?]&1'\X,)#;
M0/N9[AG,!N@U'V&JV5AYLU\93K$V3;UQJ.#'Z#UN"3X,C^8:# $K]Q).,^B&
MA^7X88&SH-W4FVI#%]L;L%1^D8!Z<JI9KX/&0D[(OPF=N%98W6N-8C<!1/%"
MZ%;\*/RELFS;;MM2*6?7[8G:[.&9AZNO+"%OT(AZ)_F5W6KD($G7?HI4Y^7U
M)&\9\*0JG-XT#FH62:24TKU;%@D\2P@%=8TY4O(&)NSWG+#;??0C8W=_9Y&+
MO<^PZ-@C]3@>!X&4($Z(&2+R).B/>>TDJ) 9/)\2*1+<^042:1?DHLZG"G$^
M0V6(G"W26U-K> 1_3)0A(!"/K(?N.WD)<5++>T3NG3?Q6;!*@BN#)?TP@:-/
M86IX=D "KJ\K7^L[^@4Q>OR2D8R2LS[A#((.C6($A0O47A^[])?9R**5.8^C
M1AO0V\\EV*QS(72U]7N!G6<O3"< IIETVV%2/[$5$DBX21UG[>EVA8TK%M^U
M)MO]H<GN:S5?O<%TQ]%_O3U^<WR>[">4__@)?GASD.,=A_'[\>G^P?E^<O[V
MZ'3_X]&G\^.#LS0Y/CE 4=W$@/8>[>TE1^\_OOOPY]$1O/;#P7\F'S^='KS=
M/SM*/K[;/]G0N,X^O3D[.#W^>'[\X239_^WTZ.@]R)H9C",[SHOV[('N/-_>
M>88YG>^_>7>4'!R]>W?V<?_@^.2W?SQX](#^_G'_\%#_W1/^-Q].#X].Z><R
M!O[)0S@Q[_8_GAV]T']8.NUPC5K+@(>*AGCZ6OYPJ ?R%,8!"W%^:'_SNWR;
MIVJ'K#_H/^#)<_US^->I\RH])4=;Y%,DN'V1797Y*+G9E%X'@X-M>6!3C[?[
M-Y[>#U+ZI.\$3F[:60:+8?:\_0D:D7$VT3E^052U=QGA]_OO?N]F^V EZ)M)
MSW_C/TXQ[1(PYATDPCT:\!]4$C>UIV[66O?X]8%F_D'KAZRCN6;910//(9U#
MT+L:Z32PDQ&B *;*R&QE[)<&J? #Q5?^/<=BKZS?.\?\[DS!F@UKN(:FPYV$
M+P3MZ'(LS"(ZQ3T\#I7PUZ^'W4G^._(/K<% ,+9UI-?!G:>;;.$C.$V/?^>T
M/#-28H'[$&2.JX,B)8*.>V^[NCM!QF@))9C#JT=UQJ_F&-\^!JC)]W<&ZWX"
M['#]$7?\@<?_+=T%<"+UWAE:>Z*@7@*M%M@QE\4'@')8[']SY (>+U63E'E-
MF"+_)OT\(Z'Q2 MX E]BOP..['$#0=!X<(X+3B53[&5B>Q LF\1\AF.##R]9
M!5PXC6 +)@C?[/>6+:!!+^)"('E>/FX4):2>VAZ%;B,) =<=VXYS@OSN 'E_
M0PEZ;"6HW[,B%"34$5&!ZRDT@ 8RUH5Y'TJ.QZU.CG<HMAEOO\\/O@'6KAXS
M4FQE)/8\^_+PE&@M3%3]N,$65^3Y%R0XY/*"3$XXFFB@NM0)W,M&_F(\ZKB"
M^/;[] 3W*1345IEI<VG9\]J-1&Q3.="6\\F\8.I'@>^M45XOJ7P'GQ?4^C@5
M\_&R=M&3[:GD8_CAJ*1CY3>>;R>C4H$MV#ETSU57GI-P.ZDBD^B9F';5U$)F
M#6S"M]_\IW1(T3(Q\'-$J\X,]8RNZK5-X/*FIFWF,RPUN 3@F->Q]9\LEG3/
M(C *Q8X$!%*'J-\6#NO;+]+/ L/0:@M1*-65JOUL!->!>G Q_'$^F1',C^X#
M'S(]7;HVJ<YP.D(D:=6.0V3ANI'>A,Z%ZJI@%W#6A)@SV&>O<Y^)=?KD!!($
MIMW/*!7/R9D!W&E<F=:N,F&*Z$)*US5/I^X&4%OCV&'9I[+ 5 M(JH/.#('C
M>]GLAC[I,%XZZYW+[%[7>O#]'I9+""$& [>QK%CKZ)K#O;#$#;5JJCV4G'?3
M\#DQS  &6/;MA?@7F"AML)S/LI3SR=0##>.[8<>9=Z#)OH#J4U)'RY O_*'4
M9BY1[:%*$Z80_53.HVI:T4I'U'5V=;+&C;RTK9 M#L_H=6Y;* >,1[BIB2V9
MH[8*NJTO(04:M^@CJ/.(H&@F2C?N8NL"')H2^YDB"O]"Q 8;(:^@?MFV2^MV
MUL)<3>KD$.$4E%1 G2/C048%XR?201#\)OE9V%G,:[,UQGM/8=]M(BKE'YJ7
M3@W!NZF06KDO\(2'E6\IY60IR0_EC';?!JCBM%7ELV9,U@"1;[%;U66O:;_*
M\E]U0F\G2(HA: _DZ(#3>OS:N$/QOG%K&+9:%.]H=[(^0_((-3(W([6T7V)?
M#353S=J&<U7.+[#8@IXL8MRN/8,=B_B)D;4@K,[]+T;4"(\N$2CUY6O$"F&@
M+K-B[/D79*[KR66FS@\!U_KF$(0U!EZ"EDGN4EQFKLVPI0-'=,D;U;1]?QX*
M>EY>;7&LIEA2!S_R5S>Y3<D8=$3'"?U19:#56W0!&@=$SE%,R=]MJUTQX\JQ
M,77>-'V_6$OPKO/ B)T-++:)9W)G7XQ>GC"/(E8[3)5_RYH"\[8'M>KL,SY\
M G\R/\(!&WU@V7YXE> .S[&X0F6-!@F&P]E!T@?'G'2PYVT@$*D"_>H4%V!H
MFQT94#G8$/D$0Y06D4.0![@];[]).:?$&;E0D[U*=$*U[B+*Y;X+'?XAEUA8
M"\"]$B2B\$8%FCA89L^LM1,D8KJFI<*]#=K:U:!>K%J9ED&Y7=OZ-2U1V6'#
MG;H?H8[45M.(N5R K<5.:^(E5[1N:8BRG$"L\\[E]AM1:(AOOE:MAF6GC[JA
M79P^DT4@,K>?/IV$RUQ)-SR>Z;S(^%"PH;L!G.6S5CN5;E"R='9RU! YG>5P
MSA:Q8QF*'^*4("UKNHW==S6[*F54:B=@K7D(W 9#Q$-JWJLS$OQ]4\Y-(J$]
MV$BBPC>-UB"8 4^E )-2[ZM'"IO4B[I!-G_-%2:X)%0.@FILG7&LW]44<:;7
M27=Y_[=W,Y^S<'1D/V+XVY7P6];8*^"WVB"SK:=0'I&:"KR(1M?XNM!9"M2B
M5-"3\2&6*<[U]0>JN<88O'F7[8)+Y@B-6=0)QSUFJJ(;;D24AI4J3-V$?L9.
M\BL2P''7(!X<F(NH>Z1($YL]S1NMKC.XZA3RDX$T-\QDBIUCY6^F.H6[W,'<
M+O.9H3;-*FYF8MV7^0 5H%YU-77R+<-B7N-I\5%P78ONG)9+W5I*SZ/T87>2
M@:'"&SE+YC$')=Q39(U?XIY+Y(G")6HDS8#FB/#31M.G*;&@T8#L3P^IPISO
M!?WL5*I@#<<'/F<#;:D>M>L,(_C,O.[WX@<G[8IK@_%V75:?A7#:-#IF3DDT
M'"J/4K*U>NERAYRWD-I;^]$.CEN8T-@YW8XX-(>^@\)):Y5^N\&<(].VV6-,
M??7F]?X,"8KS+X0/>_,Z:YH,2743H=K0U9GDGF>%W-@BYLZ8<,9Z:3I?\2;V
M"@,-[]P..('(PL(Q1.IEJ:/H^+Z<F!P9 (HOM&]CJWGER(7-@L=.,2A460L)
MD*P7Y(TS21JK," ,<* )P7A:Y<DZ4MSOK14J]C84%YOYM]P]H)\ZI?C$/?U7
M2Y_M[GIYSECX.VX_LN0$,^';TY1W3@VU:^>,&;VM.Z#IL"88-!?:J>@V9=K&
MX_]*K-[>SW?$ZOWR>'-8/:TO-7SEC.+"]P*L^F9S$.JB17)"\:D7=QG]_PY@
MX$U@@-_^WQL"'H9' 0P4[+;T0YQ^B-.M4- _Q.:'V/P0F__=8O-MP.7'R?[!
M?YY\^./=T>%O1\G^R6'RZ01LX+-S_./YV_US^-?Q6=)1<W-\<O#N$UK7R?'Y
M6;+_\>/1R>'QP=$9/>C]G\G'_=/SXX/CC_OTO>,3+&[BTJ$_CM^]Z_=.C][O
M'],OCG[]]>@ 7W;ZX=-O;S]\ L_]TP$\Z>SX]Z/D _SR%-_R$?[SX? ,QO@.
M?I7L__KK\>E[>/CO1^_^3,Z/3M\?G^R?'QTF;_Y,WA^U/++_E2[&=UT.Y&Q>
MXF]7$A5]^1&F85_L[CRBW+#K8S_4/[S1&<'*G]&/TI]-C\)5DA]_7';?U:YU
M[./7V8CO8.+?E7'XU]#"9Y1HE)[MVN$VFB TF;['POZ]'U7]7Z6J_\V/JOZ_
M?E7_R0=8&C3UD].CPT\'Y## 7X[>@5L %OW!AY/ST^,WG]@!>?_ADU/Q_VT'
M^N$T1C7P]=_[Q_'YV\/3_3_VWZV:^/UXA@>7:OB9R1R9^S=Y4WZY39+K1F_]
M][\]_^7)DY=X@'&2=(Y/=044:7XN8I1NV4$!I#[GE,OB/"EH(#4*VQ!B&JK5
MGF;L5@0GMRH(IF3F0%T04M"K2D[E;VX9+DS-8Q? T6NLN$ FJ-USKCR4I4 S
M+KF1-OQ'/GN-0)[:08==,M\2YN"7E7Y*]M:R\S'P[\4W3VC^FUVQ8)E( G#3
MEU;TV]7[VE(:BI=-R6MZ<BPDG0^XIUZSK)9ODHU4@/E6B<QWJ; OJX01$=?
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MQ:$/7C@>:A32?I"^&V!+%"MHT&2Q2.;ZAI$A>!]@O5T\',4H3?<8M82C1..
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M="!$=0F^:-N"_!^V0JZ#O=(\Z /F<=?U&?///+RIC_P+4$L! A0#%     @
MO8#(5(GH@:R0$P  'J<   X              ( !     &0S,3$W,S-D.&LN
M:'1M4$L! A0#%     @ O8#(5/4"0G:R2P  $GT! !$              ( !
MO!,  &0S,3$W,S-D97@Q,#$N:'1M4$L! A0#%     @ O8#(5%%_7:5$ P
M1 L  !$              ( !G5\  '9I<G@M,C R,C V,#@N>'-D4$L! A0#
M%     @ O8#(5%_!,LQ[!@  ND8  !4              ( !$&,  '9I<G@M
M,C R,C V,#A?;&%B+GAM;%!+ 0(4 Q0    ( +V R%2Z5N(%P00  #8L   5
M              "  ;YI  !V:7)X+3(P,C(P-C X7W!R92YX;6Q02P4&
/  4 !0!  0  LFX

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
